Morgan Stanley (BIVI) discloses 896,822 BioVie shares, an 11.9% stake

Rhea-AI Filing Summary

Morgan Stanley and Morgan Stanley Smith Barney LLC report beneficial ownership of Class A common stock of BioVie Inc. They disclose aggregate beneficial ownership of 896,822 shares, representing 11.9% of the class.

The reporting persons state they have no sole voting or dispositive power, but report shared dispositive power over 896,822 shares. The Schedule 13G/A is filed on behalf of Morgan Stanley as a parent holding company and Morgan Stanley Smith Barney LLC as a broker-dealer and investment adviser, with additional details for relevant subsidiaries referenced in an exhibit.

Key Figures

Shares beneficially owned: 896,822 shares Percent of class: 11.9% Shared dispositive power: 896,822 shares +1 more

4 metrics

Shares beneficially owned 896,822 shares Aggregate Class A common stock beneficially owned by Morgan Stanley entities

Percent of class 11.9% Percentage of BioVie Inc. Class A common stock beneficially owned

Shared dispositive power 896,822 shares Shares over which the reporting persons have shared dispositive power

Sole voting power 0 Shares for which the reporting persons have sole power to vote

Key Terms

beneficially owned, shared dispositive power, parent holding company, broker-dealer

4 terms

beneficially owned financial

"this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared dispositive power financial

"Shared Dispositive Power 896,822.00"

parent holding company financial

"If a parent holding company has filed this schedule, pursuant to (ii)(G)"

broker-dealer financial

"Morgan Stanley Smith Barney LLC ... BD, IA"

A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 05:21 PM Accepted by SEC EDGAR 08/07/2026 - 05:21 PM Learn about SEC filing dates

FAQ

What percentage of BioVie Inc. (BIVI) does Morgan Stanley report owning?

Morgan Stanley and Morgan Stanley Smith Barney LLC report beneficial ownership of 11.9% of BioVie Inc.’s Class A common stock. This percentage is based on their aggregate beneficial ownership as disclosed in the Schedule 13G/A filing.

How many BioVie Inc. (BIVI) shares does Morgan Stanley beneficially own?

They report beneficial ownership of 896,822 shares of BioVie Inc. Class A common stock. This share amount corresponds to the 11.9% of the class disclosed in the ownership section of the Schedule 13G/A.

What voting power does Morgan Stanley report for its BioVie Inc. (BIVI) holdings?

The reporting persons disclose no sole voting power over BioVie Inc. shares and indicate shared voting power in the cover page responses. Detailed voting power information is tied to the specific responses for Items 5 and 6.

What dispositive power does Morgan Stanley have over BioVie Inc. (BIVI) shares?

Morgan Stanley and Morgan Stanley Smith Barney LLC report no sole dispositive power and shared dispositive power over 896,822 shares of BioVie Inc. Class A common stock, as shown in Item 8 on the cover pages.

Who are the reporting persons in the BioVie Inc. (BIVI) Schedule 13G/A?

The reporting persons are Morgan Stanley and Morgan Stanley Smith Barney LLC, both organized in Delaware. Morgan Stanley files as a parent holding company; Morgan Stanley Smith Barney LLC is classified as a broker-dealer and investment adviser.

Where are Morgan Stanley’s principal offices related to this BioVie Inc. (BIVI) filing?

Both Morgan Stanley and Morgan Stanley Smith Barney LLC list their principal business office at 1585 Broadway, New York, NY 10036. BioVie Inc.’s principal executive offices are listed in Carson City, Nevada.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

BIOVIE INC.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

09074F504

(CUSIP Number)

07/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 09074F504

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 896,822.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

896,822.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

11.9 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

CUSIP Number(s): 09074F504

1

Names of Reporting Persons

Morgan Stanley Smith Barney LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 896,822.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

896,822.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

11.9 %

12

Type of Reporting Person (See Instructions)

BD, IA, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: BIOVIE INC.
(b)	Address of issuer's principal executive offices: 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
Item 2.
(a)	Name of person filing: 1: Morgan Stanley 2: Morgan Stanley Smith Barney LLC
(b)	Address or principal business office or, if none, residence: 1: 1585 Broadway, New York, NY 10036 ;2: 1585 Broadway, New York, NY 10036
(c)	Citizenship: 1: Delaware 2: Delaware
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP No.: 09074F504
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 11.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.2
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	08/07/2026

Morgan Stanley Smith Barney LLC

Signature:	David Galasso
Name/Title:	Authorized Signatory, Morgan Stanley Smith Barney LLC
Date:	08/07/2026

Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).